In 2017, retail sales of analgesics saw strong current value growth, driven to a great extent by price increases. This was mostly due to inflationary pressures and a weakening local currency. Currency plays a significant role, as most branded analgesics and/or the active ingredients used to manufacture them locally, are imported. Over the forecast period anticipated economic growth below expectation, increasing inflation, may erode consumer purchasing power, and a further deterioration of the ex...
Euromonitor International's Analgesics in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Get a detailed picture of the Analgesics market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market’s major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.